(Date:11/19/2009)...Pa. and WALTHAM, Mass., Nov. 19 Ar...rces find that the leading driver of antibiotic se...-spectrum activity against gram-positive and gram-...s that can cause nosocomial pneumonia, surveyed Eu...for agents that provide appropriate coverage again...
(Date:11/19/2009).... 19 /PRNewswire/ - Aegera Therapeutics Inc. annou...ndomized Phase 2B study of AEG35156, a targeted an...ultiple oncology indications. ,, The study, ent...he X-Linked Inhibitor of Apoptosis (XIAP) Antisens...arabine and Idarubicin in AML Following Failure of...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies Form Intern...nate Best Practices in Risk Reduction ,Five Memb...e Synthesis Capacity , (P...;s leading gene synthesis companies today announce...g protocol to promote biosecurity in the gene synt...
(Date:11/19/2009)...A, Austria, November 19 AFFiRiS AG... product candidate at an unexpectedly early,stage ...ned to enter into,Phase II clinical trial early in...llows the completion of two Phase I trials with th...fast decision on the first interim,analysis of the...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3...pril 22 ACCESS PHARMACEUTICALS, INC. (OTC Bulle...), its proprietary polymer-based oral mucositis pr...ece and the Nordic countries by its European comme...pharmaceutical company dedicated to the provision ...critical care. , , Under a license from Access P...
...Can Influence New Product Development and Innovati...t end-user study from Frost & Sullivan,s Pharm...riety of critical dynamics of drug delivery approa...ians, nurses and patients provided insight on fact...e vs. office administration parameters, and barrie...
...HAI, April 22 /PRNewswire-Asia-FirstCall/ -- China... "the Company"), a leading Chinese firm,specializi...eting and,distribution of probiotics products, tod...nong Group ("Dabeinong") to supply probiotics as b...er the initial purchase order, which has already b...
Other Biology Technology:Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm 2Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm 3Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males 2Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males 3China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed 2China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed 3.../antibody delivery using PULSin may be superior to...unlike traditional transfection, with PULSin you c... time course of proteins in cells. Likewise, deliv...ation than traditional RNA interference experiment...
...XY is an automated instrument with a thin silicon ... light or fluorescence microscopy. Biaxial strain ...broblast cells can be simulated by mechanical stre...r strain chamber. Strain can be applied simultaneo...
Mechanical Cell Strain Instrument ST-160 Microscope Mountable from B-Bridge International
...lation is a post-translational modification that p...cluding immune regulation, inflammation, cell-to-c...logy has developed two lectin based Glycoprotein I...m Agglutinin (WGA), that allow isolation of glycop...
Biology Products: